NCT06321887View on ClinicalTrials.gov

EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD

PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2025

Conditions
Inflammatory Bowel DiseaseIron Deficiency Anemia
Interventions
DRUG

Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron)

Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron) daily for 8 weeks (N=10).

DRUG

Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron)

Ferrous fumarate syrup 5ml/140mg (45mg elemental iron) daily for 8 weeks (N=10).

DRUG

Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron)

Ferrous fumarate syrup 5ml/140mg twice daily (90mg elemental iron) for 8 weeks (N=10).

Trial Locations (1)

Unknown

RECRUITING

Liverpool University Foundation NHS Trust, Liverpool

All Listed Sponsors
lead

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV